Results 31 to 40 of about 52,960 (265)
Human Vaccines & Immunotherapeutics, 2021 Acute disseminated encephalomyelitis (ADEM) is an autoimmune, central nervous system demyelinating disorder that follows antecedent immunologic challenges, such as infection or vaccination.
T. J. Martin +6 more
doaj +1 more source
Adem Dema për Adem Demaçin [PDF]
Punimi trajton njërën prej veprave më të mira të Adem Demaçit: romanin autobiografik Dashuria kuantike e Filanit, në të cilën, duke rrëfyer me “kapërcime”, autori mbulon një kohë rreth gjysmëshekullore.
Bashkim Musliu
core +2 more sources
L�encéphalomyélite aiguë disséminée chez l�enfant
The Pan African Medical Journal, 2014 L'encéphalomyélite aiguë disséminée (ADEM) est une maladie inflammatoire, démyélinisante, multifocale intéressant principalement la substance blanche du système nerveux central. Elle est rare mais non exceptionnelle chez l'enfant.
Ilham Tadmori +7 more
doaj +1 more source
Diagnostic odyssey of acute disseminated encephalomyelitis in children
Scientific Reports, 2021 We aimed to determine whether acute disseminated encephalomyelitis (ADEM) diagnosis in children is delayed, and if so, to identify the clinical risk factors of delayed diagnosis. Standardised data were collected from children with ADEM from 2003 to 2020.
Yoko Takahashi +2 more
doaj +1 more source
Successful treatment of post–COVID-19 acute disseminated encephalomyelitis with urgent immunotherapy and neurointensive management: a case report [PDF]
Journal of Neurocritical Care, 2022 Background Acute disseminated encephalomyelitis (ADEM)-like white matter disease, a rare complication of coronavirus disease 2019 (COVID-19), is a potentially life-threatening neurological disorder.
Jung Seok Lee +2 more
doaj +1 more source
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2023 Background Acute disseminated encephalomyelitis (ADEM) is an extremely rare complication of COVID-19 vaccination with very few reports worldwide. Concomitant peripheral nervous tissue involvement in ADEM is very uncommon.
Jomal Mathew Chittilappilly +1 more
doaj +1 more source
ADEM-_Supp-Table-Sept23 - Increased Intracranial Pressure in Acute Disseminated Encephalomyelitis
, 2019 ADEM-_Supp-Table-Sept23 for Increased Intracranial Pressure in Acute Disseminated Encephalomyelitis by Rotem Orbach, Nira Schneebaum Sender, Ronit Lubetzky, and Aviva Fattal-Valevski in Journal of Child ...
Nira Schneebaum Sender (6018467) +3 more
core +1 more source
Frontiers in Immunology, 2022 BackgroundAcute disseminated encephalomyelitis (ADEM) is a rare demyelinating disorder that is often misdiagnosed. To improve early diagnosis, we performed a systematic review and meta-analysis of clinical features, outcomes for ADEM in adults.MethodsThe
Kunyi Li +5 more
doaj +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
MOGAD Is the Most Common Cause of Isolated Optic Neuritis in Children
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objectives The study aimed to characterize the clinical features, etiologies, and outcomes of isolated, first‐time pediatric ON in the post‐MOG‐IgG era. Methods This was a single‐center retrospective cohort study at Texas Children's Hospital of patients diagnosed with first‐time ON between 2018–2024, with follow‐up data collected through 2025.
Chaitanya Aduru +13 more
wiley +1 more source